Eva Susanne Dietrich | Professor, Departments for Clinical Pharmacy and Regulatory Affairs
University of Bonn

Prof. Dr. Eva Susanne Dietrich has extensive experience in pharmaceutical market access, benefit assessment, reimbursement, and health policy in Germany. She is a pharmacist by training and has worked for more than 25 years at the interface of evidence-based medicine, health economics, statutory reimbursement, and pharmaceutical regulation. Eva Susanne Dietrich has held senior positions in the German healthcare system. She served as Head of the Department of Drugs, Remedies and Aids at the National Association of Statutory Health Insurance Physicians (KBV) and was a deputy member of the Federal Joint Committee (G-BA), the central decision-making body defining reimbursable healthcare services for statutory health insurance in Germany. She also represented providers in G-BA subcommittees, including those on medicines and rules of procedure, and contributed to expert work on off-label drug use on behalf of the Federal Institute for Drugs and Medical Devices (BfArM). After her work in physician self-government, she joined one of Germany’s largest statutory health insurance funds, where she established and directed a scientific institute and led the Management Division Health Sciences. In these roles, she gained broad experience in payer perspectives, health technology assessment, evidence evaluation, health economic analyses, and the integration of medical innovation into the German reimbursement system. Since 2018, Eva Susanne Dietrich has been founder and head of the Institute for Evidence-based Positioning in the Healthcare Sector. As an independent consultant, she advises pharmaceutical companies and consulting firms on German market access, AMNOG strategy, benefit assessment, pricing and reimbursement, and evidence generation. She has authored more than 50 AMNOG dossiers and supported more than 700 market access projects, including early consultations, strategic dossier planning, G-BA procedures, written statements, hearings, and negotiation preparation. Eva Susanne Dietrich holds an honorary professorship at the University of Bonn, where she teaches health economics, evidence-based medicine, benefit assessment, and drug regulatory affairs. She studied pharmacy at the University of Heidelberg, obtained her PhD in pharmacoeconomic methodology, and holds a Master’s degree in Health Technology Assessment and Management from the University of Barcelona.